According to the Medicines and Healthcare products Regulatory Agency or MHRA, class IIb devices are generally regarded as posing a medium risk to users.
Because of their inherent risk, class IIb device manufacturers must comply with various regulations to ensure patient safety & data security and privacy.
For more information on this feel free to check out our free CPD certified course on digital therapeutics in the UK, found on our course website.
Comments
0 comments
Please sign in to leave a comment.